Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The DEPT. OF THE ARMY -- USAMRAA has issued a Tender notice for the procurement of a Dow Breast Cancer, Transformative Breast Cancer Consortium Award in the USA. This Tender notice was published on 05 May 2026 and is scheduled to close on 30 Sep 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 140655450, while the tender notice number is HT942526BCRPTBCCA and Registering on the platform.
Procurement Summary
Country: USA
Summary: Dow Breast Cancer, Transformative Breast Cancer Consortium Award
Deadline: 30 Sep 2026
Posting Date: 05 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140655450
Document Ref. No.: HT942526BCRPTBCCA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33184410 - Internal breast prosthesesPurchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details Tender Details Summary: The Fiscal Year 2026 (Fy26) Breast Cancer Research Program (Bcrp) Transformative Breast Cancer Consortium Award Supports Collaborations And Ideas That Will Transform The Lives Of Individuals With, And/Or At Risk For, Breast Cancer And Will Significantly Accelerate Progress Toward Ending Breast Cancer. Applications Must Propose A Synergistic, Highly Integrated, Multidisciplinary And Multi-Institutional Consortium Of Leading Scientists, Clinicians And Breast Cancer Consumer Advocates That Will Address A Major Problem In A Way That A Single Investigator Or Group Could Not Accomplish. The Consortium-S Collaborative Efforts Must Make A Transformative Impact In Breast Cancer. All Applications Must Address At Least One Of The Fy26 Bcrp Overarching Challenges Or Provide Adequate Justification For Exception. If The Application Addresses A Different Fundamental Issue, The Application Must Couple It With At Least One Of The Overarching Challenges.Distinctive Features: This Funding Mechanism Allows For Up To Five Principal Investigators (Pis) Which Includes The Consortium Director And Three Or Four Project Team Pis. Applications Must Include At Least One Breast Cancer Consumer Advocate Per Project Team. Only The Consortium Director Will Submit A Pre-Application, But All Pis Will Need To Submit At The Full Application Stage. Be Advised, Failure To Submit All Associated (Consortium Director And Project Team Pis) Applications By The Full Application Deadline May Result In Administr... Documents
Posted Date: 2026-05-04 00:00:00
Funding instrument type: Cooperative agreement
Similar Tenders
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google